News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
232 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (232)
2 (101)
3 (1)
4 (13)
5 (26)
6 (344)
7 (346)
8 (264)
9 (107)
10 (31)
11 (18)
12 (255)
13 (267)
14 (212)
15 (206)
16 (111)
17 (4)
18 (5)
19 (157)
20 (226)
21 (187)
22 (190)
23 (79)
24 (1)
25 (3)
26 (175)
27 (201)
28 (178)
29 (232)
30 (88)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
Medexus Pharmaceuticals entered into an amendment to the company’s revolving credit facility with a syndicate of lenders agented by MidCap Funding IV Trust.
September 29, 2022
·
6 min read
FDA
FDA Approves New Treatment Option for Patients with ALS
The U.S. Food and Drug Administration approved Relyvrio to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig’s disease.
September 29, 2022
·
3 min read
FDA
Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS
Amylyx Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved RELYVRIO™ for the treatment of adults with amyotrophic lateral sclerosis.
September 29, 2022
·
11 min read
FDA
Jaguar Health Subsidiary Napo Pharmaceuticals Announces Activation by FDA of Investigational New Drug (IND) Application for NP-300, a Novel Drug Candidate for the Symptomatic Relief and Treatment of Diarrhea from Cholera and Other Pathogens
Napo Pharmaceuticals, Inc. today announced the activation by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for Napo’s NP-300, a novel drug product candidate for the symptomatic relief and treatment of moderate-to-severe diarrhea.
September 29, 2022
·
5 min read
Deals
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - Sept. 29,2022
FSD Pharma Inc. today announced that on September 27, 2022 it received a written notification (the “ Notification Letter ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq’s rules for continued listing on the Nasdaq Capital Market.
September 29, 2022
·
5 min read
Biotech Beach
Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has made a capital investment in Diabetes Reversal Group, LLC.
September 29, 2022
·
2 min read
BioMidwest
Neogen® Launches New Genomic Management Technology
Neogen ® Corporation (NASDAQ: NEOG) has launched the new Encompass ™ platform for bovine genomic results management and visualization.
September 29, 2022
·
2 min read
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
Acasti Pharma Inc. announced the voting results from its Annual General and Special Meeting of Shareholders which was held virtually on Wednesday September 28, 2022.
September 29, 2022
·
7 min read
Drug Development
Avidity Biosciences Announces the Phase 1/2 FORTITUDE™ Trial of AOC 1020 in Adults with Facioscapulohumeral Muscular Dystrophy
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the Phase 1/2 FORTITUDE™ clinical trial of AOC 1020 in adults with facioscapulohumeral muscular dystrophy (FSHD).
September 29, 2022
·
10 min read
Beyeonics Vision has completed the CE Mark registration for its Beyeonics One™ ophthalmic exoscope
Beyeonics Vision, a medical device company, announced today that it has completed the registration process and received the CE Mark in Europe for its patented Beyeonics One™, a fully digital 3D surgical visualization platform.
September 29, 2022
·
2 min read
Previous
17 of 24
Next